Clinical Trial Update: Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting [Phase 4]

View source ↗

Summary

Phase 4 trial examining how ondansetron dose and timing affect postoperative nausea and vomiting outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Post-operative Nausea and Vomiting | Phase 4 | Status: COMPLETED | Results posted: 2020-07-20